Latin America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market 2023
Latin America attention deficit hyperactivity disorder (ADHD) therapeutics market is expected to reach USD 1.37 billion by 2023
(EMAILWIRE.COM, August 23, 2018 ) According to the report Attention Deficit Hyperactivity Disorder Therapeutics Market, published by Market Data Forecast, market is expected to reach USD 1.37 billion by 2023 from USD 0.82 billion in 2018, growing at a CAGR of 10.90% during the forecast period 2018-2023.
Attention Deficit Hyperactivity Disorder(ADHD), is one of the most common neurological/psychiatric disorders among children and adolescents. ADHD is commonly observed in children (<12 years age) as compared to adolescents. ADHD is also described as hyperkinetic disorder/ attention deficit disorder or neuropsychiatric disorder. The exact cause for the ADHD is not clear but, expected to be resulted due to genetic factors and environmental influences. ADHD results in improper functioning of nervous system that led to attention deficit and hyperactivity/impulsiveness condition.
ADHD is characterized by certain symptoms include easy distraction & striving to maintain focus on one task, unable to remember things, impatience, and being continuously in motion, among others. The symptoms of Attention Deficit Hyperactivity Disorder Therapeutics (ADHD) are controlled by different modalities such as medication (stimulants-amphetamines; non-stimulants- atomoxetine), psychotherapy (behavior therapy, cognitive behavioral therapy), and education/training (parent management training, family training).
Increasing involvements from public organizations, rising public conscious towards the better health conditions, and presence of effective therapeutics for the treatment of ADHD are driving the growth of Attention Deficit Hyperactivity Disorder Therapeutics therapeutics market in Latin America. However, presence of stringent regulatory guidelines and high cost of the medication for ADHD are expected to restrain the growth of Attention Deficit Hyperactivity Disorder Therapeutics therapeutics market in Latin America.
Get a comprehensive overview of the Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Drivers & Restraints
The Latin America Attention Deficit Hyperactivity Disorder Therapeutics market is primarily driven by factors like rising number of patients with learning disability, rising treatment solutions, increasing initiatives by government towards adopting neurological disorders therapeutics among others. However the market is restrained by factors like high cost of medications which are to be taken for a long time, high cost of psychotherapy and low adoption rate this therapeutics market.
Get accurate market forecast and analysis on the Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/request-sample
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Segmentation
By Medication Type
Stimulants
Amphetamines
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
Non-Stimulants
Atomoxetine
Bupropion
Guanfacine
By Psychotherapy
Behavior therapy
Cognitive Behavioral Therapy
Interpersonal Psychotherapy
Family Therapy
By Education or Training
Parent management training
Social skills training
School-based interventions
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Overview
Growing healthcare industry, increasing initiatives from government to provide better treatment solutions for mental illness conditions, growing focus of foreign pharmaceutical companies on Latin American market, presence of huge population, and rising number of mental disorders are driving the growth of attention deficit hyperactivity disorder therapeutics market in Latin America region. However, high cost pertaining to the treatment and limited adoption of ADHD therapeutics are restraining the growth of attention deficit hyperactivity disorder therapeutics market in Latin America region.
The ADHD market has been commanded by stimulant treatment, with just three affirmed non-stimulant medications endorsed that can't rival stimulant medications as far as adequacy. Because of absence of confirmation for long term safe utilization of stimulants, non-stimulants are surfacing noticeably.
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Region-wise Outlook
The Latin America Attention Deficit Hyperactivity Disorder market is broadly divided into Brazil, Argentina and Mexico. Since the market is still in its nascent stages it is expected to grow at a decent pace in the coming times.
Key Questions Answered
What is the current and future Attention Deficit Hyperactivity Disorder Therapeutics market outlook in Latin America? What trends are affecting the Latin America market?
What is the competitive landscape and market share of major players in the Attention Deficit Hyperactivity Disorder Therapeutics space in Latin America?
What are the key, high growth markets that Attention Deficit Hyperactivity Disorder Therapeutics manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Attention Deficit Hyperactivity Disorder Therapeutics currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Attention Deficit Hyperactivity Disorder Therapeutics?
What are the challenges and barriers that have hindered widespread adoption of Attention Deficit Hyperactivity Disorder Therapeutics?
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Key Players
The key players in Attention Deficit Hyperactivity Disorder Therapeutics (ADHD) therapeutics market such as, Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.), and Curemark, LLC. (U.S.).
Reasons to buy Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
Attention Deficit Hyperactivity Disorder(ADHD), is one of the most common neurological/psychiatric disorders among children and adolescents. ADHD is commonly observed in children (<12 years age) as compared to adolescents. ADHD is also described as hyperkinetic disorder/ attention deficit disorder or neuropsychiatric disorder. The exact cause for the ADHD is not clear but, expected to be resulted due to genetic factors and environmental influences. ADHD results in improper functioning of nervous system that led to attention deficit and hyperactivity/impulsiveness condition.
ADHD is characterized by certain symptoms include easy distraction & striving to maintain focus on one task, unable to remember things, impatience, and being continuously in motion, among others. The symptoms of Attention Deficit Hyperactivity Disorder Therapeutics (ADHD) are controlled by different modalities such as medication (stimulants-amphetamines; non-stimulants- atomoxetine), psychotherapy (behavior therapy, cognitive behavioral therapy), and education/training (parent management training, family training).
Increasing involvements from public organizations, rising public conscious towards the better health conditions, and presence of effective therapeutics for the treatment of ADHD are driving the growth of Attention Deficit Hyperactivity Disorder Therapeutics therapeutics market in Latin America. However, presence of stringent regulatory guidelines and high cost of the medication for ADHD are expected to restrain the growth of Attention Deficit Hyperactivity Disorder Therapeutics therapeutics market in Latin America.
Get a comprehensive overview of the Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Drivers & Restraints
The Latin America Attention Deficit Hyperactivity Disorder Therapeutics market is primarily driven by factors like rising number of patients with learning disability, rising treatment solutions, increasing initiatives by government towards adopting neurological disorders therapeutics among others. However the market is restrained by factors like high cost of medications which are to be taken for a long time, high cost of psychotherapy and low adoption rate this therapeutics market.
Get accurate market forecast and analysis on the Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/request-sample
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Segmentation
By Medication Type
Stimulants
Amphetamines
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
Non-Stimulants
Atomoxetine
Bupropion
Guanfacine
By Psychotherapy
Behavior therapy
Cognitive Behavioral Therapy
Interpersonal Psychotherapy
Family Therapy
By Education or Training
Parent management training
Social skills training
School-based interventions
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Overview
Growing healthcare industry, increasing initiatives from government to provide better treatment solutions for mental illness conditions, growing focus of foreign pharmaceutical companies on Latin American market, presence of huge population, and rising number of mental disorders are driving the growth of attention deficit hyperactivity disorder therapeutics market in Latin America region. However, high cost pertaining to the treatment and limited adoption of ADHD therapeutics are restraining the growth of attention deficit hyperactivity disorder therapeutics market in Latin America region.
The ADHD market has been commanded by stimulant treatment, with just three affirmed non-stimulant medications endorsed that can't rival stimulant medications as far as adequacy. Because of absence of confirmation for long term safe utilization of stimulants, non-stimulants are surfacing noticeably.
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Region-wise Outlook
The Latin America Attention Deficit Hyperactivity Disorder market is broadly divided into Brazil, Argentina and Mexico. Since the market is still in its nascent stages it is expected to grow at a decent pace in the coming times.
Key Questions Answered
What is the current and future Attention Deficit Hyperactivity Disorder Therapeutics market outlook in Latin America? What trends are affecting the Latin America market?
What is the competitive landscape and market share of major players in the Attention Deficit Hyperactivity Disorder Therapeutics space in Latin America?
What are the key, high growth markets that Attention Deficit Hyperactivity Disorder Therapeutics manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Attention Deficit Hyperactivity Disorder Therapeutics currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Attention Deficit Hyperactivity Disorder Therapeutics?
What are the challenges and barriers that have hindered widespread adoption of Attention Deficit Hyperactivity Disorder Therapeutics?
Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market: Key Players
The key players in Attention Deficit Hyperactivity Disorder Therapeutics (ADHD) therapeutics market such as, Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.), and Curemark, LLC. (U.S.).
Reasons to buy Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results